Agios Pharmaceuticals
AGIO
#5176
Rank
NZ$2.86 B
Marketcap
NZ$48.20
Share price
0.46%
Change (1 day)
-5.06%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -NZ$0.82 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$66.04 Million. In 2025 the company made an earning of -NZ$0.8 Billion a decrease over its 2024 earnings that were of -NZ$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.82 Billion1.45%
2025 -NZ$0.8 Billion10.9%
2024 -NZ$0.73 Billion8.75%
2023 -NZ$0.67 Billion0.63%
2022 -NZ$0.66 Billion2.81%
2021 -NZ$0.65 Billion10.58%
2020 -NZ$0.58 Billion-18.41%
2019 -NZ$0.72 Billion15.72%
2018 -NZ$0.62 Billion12.99%
2017 -NZ$0.55 Billion59.61%
2016 -NZ$0.35 Billion69.32%
2015 -NZ$0.21 Billion119.28%
2014 -NZ$91.69 Million39.22%
2013 -NZ$65.86 Million69.1%
2012 -NZ$38.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.93 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.71 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.95 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-NZ$0.24 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.69 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA